Schedule a call Call720-550-6175

Patient explainer · Learn

Metabolic Syndrome

Genetic and Environmental Factors Influencing Metabolic Syndrome

By Jason Glowney, MD.

This is a detailed subject, and what it means for your situation depends on your history and your lab results. Dr. Glowney is glad to work through it with you.

Schedule a call → 720-550-6175

Genetic and environmental factors.

Metabolic syndrome is a complex condition characterized by a cluster of interconnected factors, including abdominal obesity, elevated blood pressure, high fasting blood glucose, elevated triglycerides, and reduced high-density lipoprotein cholesterol, which collectively increase the risk of cardiovascular disease, type 2 diabetes, and other chronic illnesses (Varanasi, 2011) (Phillips, 2013) (Groop, 2000) (Brown & Walker, 2016). Genetic factors predispose individuals to this syndrome, with variations in genes related to insulin signaling, lipid metabolism, and inflammation influencing susceptibility (Varanasi, 2011) (Brown & Walker, 2016) (Groop, 2000) (Povel et al., 2011). For instance, polymorphisms in the PPARγ gene, which regulates fat cell differentiation and glucose metabolism, have been associated with insulin resistance and type 2 diabetes, while variants in genes involved in lipid metabolism, such as APOA5, are more common in people with metabolic syndrome (Varanasi, 2011) (Cataldi et al., 2021) (Povel et al., 2011). Variations in genes encoding proteins that regulate blood pressure, like AGT (angiotensinogen), have been linked to hypertension, another hallmark of metabolic syndrome (Sethi et al., 2003). While genetic predisposition raises susceptibility, the interaction between these genetic factors and environmental influences often determines whether metabolic syndrome manifests (Phillips, 2013) (Groop, 2000). Environmental and lifestyle factors are critical drivers of metabolic syndrome, with a sedentary lifestyle, poor dietary habits, and excessive calorie intake contributing significantly to its development (Varanasi, 2011) (Grundy, 2016) (Saklayen, 2018). Sugar-sweetened beverages are associated with the development of metabolic syndrome and type 2 diabetes (Malik et al., 2010), and more time spent sedentary is associated with a higher risk of metabolic syndrome (Wu et al., 2022). Chronic stress and short sleep duration are additional environmental factors associated with metabolic syndrome (Varanasi, 2011) (Kuo et al., 2019) (Xie et al., 2021). The development of metabolic syndrome is the result of a complex interaction between genetic predisposition and environmental factors, with both influencing the progression and pathogenesis of this growing public health concern (Varanasi, 2011) (Phillips, 2013) (Groop, 2000) (Brown & Walker, 2016).

The metabolic dysfunction associated with metabolic syndrome is linked to a higher risk of cardiovascular disease, diabetes, and cancer (Peterseim et al., 2024) and to accelerated epigenetic aging (Nannini et al., 2019), making it a central focus of longevity medicine. Insulin resistance, a hallmark of the syndrome, arises when the body's nutrient storage pathways are exposed to a chronic energy surplus and can lead to hyperlipidemia (Samuel & Shulman, 2016). Understanding the genetic and environmental factors contributing to metabolic syndrome is important for developing targeted interventions and personalized approaches to prevention and management (Arora, 2012) (Phillips, 2013) (de Toro-Martín et al., 2017).

Given metabolic syndrome's complex and multifactorial nature, a comprehensive approach to prevention and management is necessary. Strategies to address genetic and environmental risk factors, such as promoting healthy dietary choices, increasing physical activity, and identifying and managing genetic predispositions, are essential for reducing the burden of this condition and its associated comorbidities (Mahajan & Kshatriya, 2020) (Phillips, 2013) (Brown & Walker, 2016).

The prevalence of metabolic syndrome is increasing globally (Noubiap et al., 2025), and it is often higher in the urban populations of some developing countries than in Western countries (Saklayen, 2018). Many genetic and acquired factors contribute to metabolic syndrome (Fahed et al., 2022).

The development of metabolic syndrome is driven by a complex interplay between genetic and environmental factors, which collectively increase the risk of cardiovascular disease, type 2 diabetes, and other chronic illnesses (Varanasi, 2011) (Phillips, 2013) (Brown & Walker, 2016).

The burden of metabolic syndrome is a significant public health concern, and addressing this challenge requires a comprehensive understanding of the underlying genetic and environmental factors.

The biomolecular mechanisms underlying metabolic syndrome.

Metabolic syndrome is a complex condition that arises from a delicate balance of biomolecular mechanisms, with insulin resistance at its core. Metabolic syndrome seems to be the end result of a lifestyle that promotes high-calorie foods and minimal physical activity, resulting in a state of positive energy balance. (Bidwell, 2017) Over time, excess nutrients are stored in adipose tissue, which becomes hypertrophic and dysfunctional. (Capurso & Capurso, 2012) This dysfunction leads to adipocyte stress and the release of pro-inflammatory cytokines, such as tumor necrosis factor-alpha and interleukin-6, as well as free fatty acids into circulation. (Choi et al., 2025) (Capurso & Capurso, 2012) These molecules interfere with insulin signaling pathways, promoting systemic insulin resistance. (Choi et al., 2025) (Capurso & Capurso, 2012)

In a healthy state, insulin binds to its receptor on the cell surface, activating the insulin receptor substrate proteins and downstream signaling cascades, such as the phosphoinositide 3-kinase (PI3K)-Akt pathway. (Guo, 2014) (Arora, 2012) However, chronic inflammation and an oversupply of free fatty acids inhibit this pathway in metabolic syndrome. Free fatty acids activate protein kinase C, which phosphorylates insulin receptor substrate proteins at serine residues, impairing their ability to propagate insulin signaling. (Capurso & Capurso, 2012) In genetically modified mice, kinases including IKKbeta and JNK, activated by inducers of insulin resistance, induce uncontrolled serine phosphorylation of insulin receptor substrate proteins. (Tanti & Jager, 2009) (Arora, 2012)

Another critical component of metabolic syndrome is mitochondrial dysfunction, including excess reactive oxygen species production and mitochondrial DNA damage, which further stimulate inflammatory pathways. (Choi et al., 2025) In insulin-resistant skeletal muscle, fatty acid and ceramide accumulation mediate mitochondrial reactive oxygen species production. (Kasai et al., 2023)

The consequences of this metabolic dysfunction extend beyond the disruption of insulin signaling. Excessive free fatty acid release rates into the bloodstream can impair insulin's ability to stimulate muscle glucose uptake and suppress hepatic glucose production. Noninfectious systemic inflammation associated with adipocyte and adipose tissue macrophage cytokine production can also cause insulin resistance. (Kirk & Klein, 2009) (Capurso & Capurso, 2012)

In addition to the impairment of insulin signaling, metabolic syndrome is also characterized by lipid and lipoprotein metabolism dysregulation. Increased free fatty acid delivery to the liver can stimulate hepatic very low-density lipoprotein triglyceride production, leading to dyslipidemia. (Kirk & Klein, 2009)

The complex interaction of these biomolecular mechanisms, driven by chronic caloric excess and a sedentary lifestyle, lies at the heart of metabolic syndrome. Understanding these underlying processes is important for developing effective interventions and management strategies for this increasingly prevalent condition.

Health consequences and individual variation.

Metabolic syndrome is associated with a significantly increased risk of cardiovascular disease and other serious health complications, including type 2 diabetes and certain types of cancer. (Peterseim et al., 2024) (Esposito et al., 2012) (Kirk & Klein, 2009) Continued research into the molecular underpinnings of this syndrome will be essential for improving clinical outcomes and reducing the burden of this complex and multifaceted disorder.

Importantly, the mechanisms underlying metabolic syndrome may vary between different populations and ethnicities. This points to the need for a personalized approach to managing and preventing this condition, considering individual genetic and environmental factors.

The biomolecular mechanisms underlying metabolic syndrome are interconnected, involving a complex interaction of insulin resistance, chronic inflammation, mitochondrial dysfunction, and dysregulated lipid and lipoprotein metabolism. Understanding these processes is important for developing more effective treatments and prevention strategies for this pervasive and debilitating condition. While the precise mechanisms may differ across populations, the core pathways involved in metabolic syndrome, such as impaired insulin signaling, chronic inflammation, and mitochondrial dysfunction, are universal. (Arora, 2012) Ongoing research in this field will continue to shed light on the underlying biology of metabolic syndrome, which could lead to more personalized and targeted interventions to improve the health and well-being of affected individuals.

Prevalence and public health.

The prevalence of metabolic syndrome is alarmingly high in many populations around the world, and it is associated with a significant increase in the risk of cardiovascular disease and other serious health complications. (Grassi et al., 2009) Urgent action is needed to address this growing public health concern through lifestyle interventions, targeted pharmacological treatments, and a deeper understanding of the molecular mechanisms driving this complex disorder.

Metabolic syndrome is a significant global health challenge with significant implications for individual and public health. By elucidating the intricate biomolecular pathways underlying this condition, researchers and clinicians can work to develop more effective strategies for prevention and management, ultimately reducing the burden of this pervasive and debilitating disorder.

Given the high prevalence of metabolic syndrome and its associated health risks, it is important to understand the underlying mechanisms driving this condition and to develop effective interventions to address it. (Grassi et al., 2009) (Selvaraj & Muthunarayanan, 2019) (Mahajan & Kshatriya, 2020)

Addressing the public health burden of metabolic syndrome will require a multifaceted approach that combines lifestyle modifications, targeted pharmacological treatments, and a deeper understanding of the underlying biomolecular mechanisms. (Grassi et al., 2009) (Selvaraj & Muthunarayanan, 2019) (Mahajan & Kshatriya, 2020) Dietary interventions, such as incorporating cocoa flavanols, have also shown promise in improving various aspects of metabolic syndrome, including insulin sensitivity, lipid profiles, and inflammatory markers. (Strat et al., 2016)

Continued research into the molecular underpinnings of metabolic syndrome and the development of personalized prevention and management strategies will be crucial for mitigating the significant health and economic burden associated with this pervasive condition. The complex biomolecular mechanisms underlying metabolic syndrome, including insulin resistance, chronic inflammation, mitochondrial dysfunction, and dysregulated lipid metabolism, are critical targets for developing more effective interventions and management strategies for this increasingly prevalent and debilitating condition.

References

Sources cited.

  1. Arora, S. (2012). Molecular basis of insulin resistance and its relation to metabolic syndrome. In Insulin Resistance. InTech. https://doi.org/10.5772/50337
  2. Bidwell, A. J. (2017). Chronic fructose ingestion as a major health concern: Is a sedentary lifestyle making it worse? A review. Nutrients, 9(6), 549. https://doi.org/10.3390/nu9060549
  3. Brown, A. E., & Walker, M. (2016). Genetics of insulin resistance and the metabolic syndrome. Current Cardiology Reports, 18(8), 75. https://doi.org/10.1007/s11886-016-0755-4
  4. Capurso, C., & Capurso, A. (2012). From excess adiposity to insulin resistance: The role of free fatty acids. Vascular Pharmacology, 57(2-4), 91–97. https://doi.org/10.1016/j.vph.2012.05.003
  5. Cataldi, S., Costa, V., Ciccodicola, A., & Aprile, M. (2021). PPARγ and diabetes: Beyond the genome and towards personalized medicine. Current Diabetes Reports, 21(6), 18. https://doi.org/10.1007/s11892-021-01385-5
  6. Choi, W., Woo, G. H., Kwon, T. H., & Jeon, J. H. (2025). Obesity-driven metabolic disorders: The interplay of inflammation and mitochondrial dysfunction. International Journal of Molecular Sciences, 26(19), 9715. https://doi.org/10.3390/ijms26199715
  7. de Toro-Martín, J., Arsenault, B. J., Després, J. P., & Vohl, M. C. (2017). Precision nutrition: A review of personalized nutritional approaches for the prevention and management of metabolic syndrome. Nutrients, 9(8), 913. https://doi.org/10.3390/nu9080913
  8. Esposito, K., Chiodini, P., Colao, A., Lenzi, A., & Giugliano, D. (2012). Metabolic syndrome and risk of cancer: A systematic review and meta-analysis. Diabetes Care, 35(11), 2402–2411. https://doi.org/10.2337/dc12-0336
  9. Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H. I. (2022). Metabolic syndrome: Updates on pathophysiology and management in 2021. International Journal of Molecular Sciences, 23(2), 786. https://doi.org/10.3390/ijms23020786
  10. Grassi, G., Seravalle, G., Quarti-Trevano, F., Dell'Oro, R., Bombelli, M., & Mancia, G. (2009). Metabolic syndrome and cardiometabolic risk: An update. Blood Pressure, 18(1-2), 7–16. https://doi.org/10.1080/08037050802677695
  11. Groop, L. (2000). Genetics of the metabolic syndrome. British Journal of Nutrition, 83(Suppl 1), S39–S48. https://doi.org/10.1017/s0007114500000945
  12. Grundy, S. M. (2016). Metabolic syndrome update. Trends in Cardiovascular Medicine, 26(4), 364–373. https://doi.org/10.1016/j.tcm.2015.10.004
  13. Guo, S. (2014). Insulin signaling, resistance, and the metabolic syndrome: Insights from mouse models into disease mechanisms. Journal of Endocrinology, 220(2), T1–T23. https://doi.org/10.1530/JOE-13-0327
  14. Kasai, S., Kokubu, D., Mizukami, H., & Itoh, K. (2023). Mitochondrial reactive oxygen species, insulin resistance, and Nrf2-mediated oxidative stress response-toward an actionable strategy for anti-aging. Biomolecules, 13(10), 1544. https://doi.org/10.3390/biom13101544
  15. Kirk, E. P., & Klein, S. (2009). Pathogenesis and pathophysiology of the cardiometabolic syndrome. The Journal of Clinical Hypertension, 11(12), 761–765. https://doi.org/10.1111/j.1559-4572.2009.00054.x
  16. Kuo, W. C., Bratzke, L. C., Oakley, L. D., Kuo, F., Wang, H., & Brown, R. L. (2019). The association between psychological stress and metabolic syndrome: A systematic review and meta-analysis. Obesity Reviews, 20(11), 1651–1664. https://doi.org/10.1111/obr.12915
  17. Mahajan, N., & Kshatriya, G. K. (2020). Prevalence of metabolic syndrome and associated risk factors among tribal adolescents of Gujarat. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(5), 995–999. https://doi.org/10.1016/j.dsx.2020.06.040
  18. Malik, V. S., Popkin, B. M., Bray, G. A., Després, J. P., Willett, W. C., & Hu, F. B. (2010). Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: A meta-analysis. Diabetes Care, 33(11), 2477–2483. https://doi.org/10.2337/dc10-1079
  19. Nannini, D. R., Joyce, B. T., Zheng, Y., Gao, T., Liu, L., Yoon, G., Huan, T., Ma, J., Jacobs, D. R., Wilkins, J. T., Ren, J., Zhang, K., Khan, S. S., Allen, N. B., Horvath, S., Lloyd-Jones, D. M., Greenland, P., & Hou, L. (2019). Epigenetic age acceleration and metabolic syndrome in the coronary artery risk development in young adults study. Clinical Epigenetics, 11(1), 160. https://doi.org/10.1186/s13148-019-0767-1
  20. Noubiap, J. J., Nansseu, J. R., Nyaga, U. F., Ndoadoumgue, A. L., Ngouo, A. T., Tounouga, D. N., Tianyi, F. L., Foka, A. J., Lontchi-Yimagou, E., Nkeck, J. R., & Bigna, J. J. (2025). Worldwide trends in metabolic syndrome from 2000 to 2023: A systematic review and modelling analysis. Nature Communications, 17(1), 573. https://doi.org/10.1038/s41467-025-67268-5
  21. Peterseim, C. M., Jabbour, K., & Kamath Mulki, A. (2024). Metabolic syndrome: An updated review on diagnosis and treatment for primary care clinicians. Journal of Primary Care & Community Health, 15, 21501319241309168. https://doi.org/10.1177/21501319241309168
  22. Phillips, C. M. (2013). Nutrigenetics and metabolic disease: Current status and implications for personalised nutrition. Nutrients, 5(1), 32–57. https://doi.org/10.3390/nu5010032
  23. Povel, C. M., Boer, J. M., Reiling, E., & Feskens, E. J. (2011). Genetic variants and the metabolic syndrome: A systematic review. Obesity Reviews, 12(11), 952–967. https://doi.org/10.1111/j.1467-789X.2011.00907.x
  24. Saklayen, M. G. (2018). The global epidemic of the metabolic syndrome. Current Hypertension Reports, 20(2), 12. https://doi.org/10.1007/s11906-018-0812-z
  25. Samuel, V. T., & Shulman, G. I. (2016). The pathogenesis of insulin resistance: Integrating signaling pathways and substrate flux. The Journal of Clinical Investigation, 126(1), 12–22. https://doi.org/10.1172/JCI77812
  26. Selvaraj, P., & Muthunarayanan, L. (2019). Prevalence of metabolic syndrome and associated risk factors among men in a rural health centre area in Tamil Nadu. Journal of Lifestyle Medicine, 9(1), 44–51. https://doi.org/10.15280/jlm.2019.9.1.44
  27. Sethi, A. A., Nordestgaard, B. G., & Tybjaerg-Hansen, A. (2003). Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: A meta-analysis. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(7), 1269–1275. https://doi.org/10.1161/01.ATV.0000079007.40884.5C
  28. Strat, K. M., Rowley, T. J., 4th, Smithson, A. T., Tessem, J. S., Hulver, M. W., Liu, D., Davy, B. M., Davy, K. P., & Neilson, A. P. (2016). Mechanisms by which cocoa flavanols improve metabolic syndrome and related disorders. The Journal of Nutritional Biochemistry, 35, 1–21. https://doi.org/10.1016/j.jnutbio.2015.12.008
  29. Tanti, J. F., & Jager, J. (2009). Cellular mechanisms of insulin resistance: Role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Current Opinion in Pharmacology, 9(6), 753–762. https://doi.org/10.1016/j.coph.2009.07.004
  30. Varanasi, V. K. (2011). Metabolic syndrome: The genetic aspect. Endocrinology & Metabolic Syndrome, 01(S1). https://doi.org/10.4172/2161-1017.s1-e001
  31. Wu, J., Zhang, H., Yang, L., Shao, J., Chen, D., Cui, N., Tang, L., Fu, Y., Xue, E., Lai, C., & Ye, Z. (2022). Sedentary time and the risk of metabolic syndrome: A systematic review and dose-response meta-analysis. Obesity Reviews, 23(12), e13510. https://doi.org/10.1111/obr.13510
  32. Xie, J., Li, Y., Zhang, Y., Vgontzas, A. N., Basta, M., Chen, B., Xu, C., & Tang, X. (2021). Sleep duration and metabolic syndrome: An updated systematic review and meta-analysis. Sleep Medicine Reviews, 59, 101451. https://doi.org/10.1016/j.smrv.2021.101451

Related patient explainers

Keep reading.

Caloric restriction and longevity

Energy-sensing pathways, animal lifespan studies, and what is known in people.

Read more →

Cardiometabolic biomarkers

ApoA-I, ApoB, and lipoprotein(a) beyond a standard cholesterol panel.

Read more →

Exercise and longevity

Heart benefits of regular exercise, and how activity relates to mortality.

Read more →

Want the inside scoop from Boulder Biologics?

What's new at the clinic, research we're excited about, and the occasional offer.

No spam, and you can unsubscribe anytime. See our Privacy Policy.